Skip to main content
    T

    Teleflex Incorporated (TFX)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE

    $128.11
    +4.82 (+3.91%)

    Market Cap: $5.22B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    97%(38/39)
    Avg Surprise
    +7.44%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$1.89
    Range$1.76 - $2.04
    12 analysts
    EPS Revisions
    11
    0
    7d
    10
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$1.83+3.0%
    60d ago$1.81+4.5%
    30d ago$1.89-0.0%
    7d ago$1.89-0.0%
    Current$1.89
    Revenue Consensus
    $565M
    Range$564M - $570M
    12 analysts
    Period ending Dec 31, 2026
    EPS Consensus$2.68
    Range$2.62 - $2.87
    11 analysts
    Revenue Consensus
    $606M
    Range$602M - $611M
    13 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$2.68---
    Sep 26EST
    		-$1.89---
    Jun 26
    Reported Aug 6
    		$1.76$1.28+37.50%Beat-52.8%
    Mar 26
    Reported May 7
    		$1.39$1.21+14.88%Beat-52.2%
    Dec 25
    Reported Feb 26
    		$1.93$3.73-48.26%Miss-50.4%
    Sep 25
    Reported Nov 6
    		$3.67$3.38+8.58%Beat+5.2%
    Jun 25
    Reported Jul 31
    		$3.73$3.37+10.68%Beat+9.1%
    Mar 25
    Reported May 1
    		$2.91$2.88+0.89%Beat-9.3%
    Dec 24
    Reported Feb 27
    		$3.89$3.88+0.26%Beat+15.1%
    Sep 24
    Reported Oct 31
    		$3.49$3.39+2.95%Beat-4.1%
    Jun 24
    Reported Aug 1
    		$3.42$3.33+2.70%Beat+0.3%
    Mar 24
    Reported May 2
    		$3.21$3.07+4.56%Beat+3.9%
    Dec 23
    Reported Feb 22
    		$3.38$3.26+3.68%Beat-4.0%
    Sep 23
    Reported Nov 2
    		$3.64$3.27+11.31%Beat+11.3%
    Jun 23
    Reported Aug 3
    		$3.41$3.21+6.23%Beat+0.6%
    Mar 23
    Reported May 4
    		$3.09$2.98+3.69%Beat+7.3%
    Dec 22
    Reported Feb 23
    		$3.52$3.44+2.33%Beat-2.2%
    Sep 22
    Reported Oct 27
    		$3.27$3.11+5.14%Beat-6.8%
    Jun 22
    Reported Jul 28
    		$3.39$3.34+1.50%Beat+1.2%
    Mar 22
    Reported Apr 28
    		$2.88$2.72+5.88%Beat+0.3%
    Dec 21
    Reported Feb 24
    		$3.60$3.53+1.98%Beat+10.8%
    Sep 21
    Reported Oct 28
    		$3.51$3.03+15.84%Beat+26.7%
    Jun 21
    Reported Jul 29
    		$3.35$2.87+16.72%Beat+73.6%
    Mar 21
    Reported Apr 29
    		$2.87$2.42+18.59%Beat+5.5%
    Dec 20
    Reported Feb 25
    		$3.25$3.05+6.56%Beat-0.9%
    Sep 20
    Reported Oct 29
    		$2.77$2.24+23.66%Beat-6.7%
    Jun 20
    Reported Jul 30
    		$1.93$1.25+54.40%Beat-27.4%
    Mar 20
    Reported Apr 30
    		$2.72$2.24+21.43%Beat+21.4%
    Dec 19
    Reported Feb 20
    		$3.28$3.22+1.86%Beat+18.4%
    Sep 19
    Reported Oct 31
    		$2.97$2.75+8.00%Beat+17.9%
    Jun 19
    Reported Aug 1
    		$2.66$2.59+2.70%Beat+7.7%
    Mar 19
    Reported May 2
    		$2.24$2.17+3.23%Beat+4.2%
    Dec 18
    Reported Feb 21
    		$2.77$2.76+0.36%Beat+13.5%
    Sep 18
    Reported Nov 1
    		$2.52$2.42+4.13%Beat+18.9%
    Jun 18
    Reported Aug 2
    		$2.47$2.41+2.49%Beat+21.1%
    Mar 18
    Reported May 3
    		$2.15$1.94+10.82%Beat+19.4%
    Dec 17
    Reported Feb 22
    		$2.44$2.40+1.67%Beat+14.6%
    Sep 17
    Reported Nov 2
    		$2.12$2.00+6.00%Beat-
    Jun 17
    Reported Aug 3
    		$2.04$1.91+6.81%Beat-
    Mar 17
    Reported May 4
    		$1.80$1.69+6.51%Beat-
    Dec 16
    Reported Feb 23
    		$2.13$2.09+1.91%Beat-

    Dividends

    Dividend Metrics

    Forward Yield1.06%
    Forward Annual Dividend$1.36
    Payout Ratio38.46%
    FrequencyQuarterly
    Pay MonthsMar, Jun, Sep, Dec

    Growth

    3Y CAGR+0.00%
    5Y CAGR+0.00%
    TFX dividend history and ex-dividend datesRun TFX in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio14.64EV/EBITDA97.56x
    Price/FCF61.58xFCF Yield1.62%
    Profitability
    Profit Margin-45.80%Operating Margin10.10%
    ROE-0.70%ROIC-0.81%
    Financial Health
    Debt/Equity1.03xInterest Coverage1.18x
    Current Ratio2.60xQuick Ratio2.12x
    Trading Statistics
    Beta0.83Avg Volume846.07K
    52-Week High$144.6452-Week Low$99.39

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$124.94
    SMA 20$124.62
    SMA 50$131.23
    SMA 200$123.73
    EMA 10$125.31
    EMA 20$126.13
    EMA 50$128.88
    EMA 200$126.91

    MACD

    Line: -1.50Signal: -2.09Hist: 0.59

    ADX

    ADX: 27.6+DI: 17.9-DI: 17.0

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down44.0
    PSAR$120.69

    Bollinger Bands

    Upper Band$128.31
    Lower Band$120.93
    %B Position592%(Upper)
    Band Width0.97

    RSI (14-Day)

    Neutral
    52.8

    Momentum Oscillators

    Stoch %K66.7
    Stoch %D64.1
    Williams %R-7.8
    ROC (10d)1.6%
    Momentum2.00
    CCI (20d)132.9
    MFI (14d)44.1

    Volatility Measures

    ATR (14d)$3.62(2.8%)
    StdDev (20d)1.84
    Hist Vol26.8%(Moderate)

    Volume Flow

    VWAP$126.82
    OBV-8.7M
    AD Line-79.3M
    CMF (20d)-0.058

    Volume Metrics

    Avg Vol (20d)845.8K
    Vol Ratio1.1x
    VWMA (20d)$124.71

    Pivot Points

    R3$126.20
    R2$125.54
    R1$124.42
    Pivot Point$123.76
    S1$122.64
    S2$121.98
    S3$120.86

    Advanced Oscillators

    TSI-14.78
    Ultimate Osc56.0
    KST-54.85

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$570.33M$548.26M$-401,866,000$913.02M$442.52M$414.26M$-552,369,000$764.38M$749.69M$737.85M$-488,139,000$746.39M
    Cost of Revenue$238.63M$240.84M$-250,454,000$461.38M$176.69M$158.83M$-326,992,000$334.20M$333.23M$321.71M$-312,737,000$330.08M
    Gross Profit$331.71M$307.43M$-151,412,000$451.64M$265.83M$255.43M$-225,377,000$430.17M$416.46M$416.13M$-175,402,000$416.31M
    Operating Expenses$258.88M$287.24M$-397,802,000$860.54M$174.69M$179.63M$-67,632,000$280.86M$299.58M$420.93M$-10,282,000$251.00M
    R&D$45.12M$44.39M$12.63M$57.23M$26.49M$25.30M$-8,098,000$38.73M$41.09M$37.30M$-4,866,000$37.58M
    SG&A$213.51M$226.01M$614,000$281.76M$137.50M$152.91M$-66,198,000$247.26M$250.63M$242.83M$-46,476,000$213.19M
    Operating Income$72.82M$20.18M$246.39M$-408,898,000$91.14M$75.80M$-157,745,000$149.31M$116.88M$-4,793,000$-165,120,000$165.31M
    Interest Income$1.42M$1.71M$680,000$2.16M$1.23M$1.49M$401,000$2.30M$1.79M$1.67M$2.19M$7.49M
    Interest Expense$29.10M$25.72M$28.13M$31.84M$21.70M$18.54M$18.60M$21.06M$21.17M$22.68M$25.72M$23.19M
    Income Before Tax$45.14M$-3,827,000$218.94M$-438,576,000$70.66M$58.75M$-175,948,000$130.55M$97.50M$-25,810,000$-188,650,000$149.60M
    Income Tax Expense$3.38M$1.01M$-30,779,000$-29,699,000$2.49M$6.42M$-26,315,000$19.63M$17.33M$-41,551,000$-5,778,000$11.94M
    Net Income$99.69M$-8,154,000$-714,330,000$-408,892,000$122.58M$95.00M$-136,656,000$111.00M$80.04M$15.29M$31.11M$137.14M
    EBITDA$124.14M$75.41M$214.65M$-329,497,000$128.88M$115.27M$-198,167,000$218.79M$185.87M$62.10M$-194,079,000$223.75M
    EBIT$72.82M$20.18M$246.39M$-408,898,000$91.14M$75.80M$-157,745,000$149.31M$116.88M$-4,793,000$-165,120,000$165.31M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about TFX

    Government Contracts

    Gov Obligations (TTM)
    $430786
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    -79.8%
    Active Awards
    130
    New Awards (TTM)
    109
    Avg Remaining Term
    12.5 mo

    Top agency: Department of Health and Human Services at 47.8% of trailing twelve month obligations across 3 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C25926P0550Department of Veterans AffairsDepartment of Veterans Affairs$42120Jul 10, 2026
    36C25226P0212Department of Veterans AffairsDepartment of Veterans Affairs$41300Apr 21, 2026
    36C25026P0825Department of Veterans AffairsDepartment of Veterans Affairs$39524Jul 24, 2026
    36C24826P0776Department of Veterans AffairsDepartment of Veterans Affairs$30043Jun 8, 2026
    75H71025P01195Department of Health and Human ServicesIndian Health Service$21500Sep 17, 2025
    36C26026P0129Department of Veterans AffairsDepartment of Veterans Affairs$18900Dec 5, 2025
    36C24226P0544Department of Veterans AffairsDepartment of Veterans Affairs$17843Apr 9, 2026
    36C26126P0828Department of Veterans AffairsDepartment of Veterans Affairs$15163Jul 1, 2026
    SPE2DS25P1535Department of DefenseDefense Logistics Agency$9000Aug 11, 2025
    SPE2DS25P1508Department of DefenseDefense Logistics Agency$9000Aug 5, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Teleflex completes 102-patient study enrollment for Teleflex stock

    Teleflex announced the completion of enrollment for its BIOMAG-LL clinical study with 102 patients across 14 European centers. The study evaluates resorbable magnesium scaffolds for coronary lesions...

    ad-hoc-news.de•10/15/26•Somewhat-Bullish

    Teleflex Inc. stock outperforms competitors despite losses on the day

    Teleflex Inc. (TFX) shares decreased by 1.00% on Tuesday, closing at $124.44, despite an overall negative day for the stock market where the S&P 500 Index and Dow Jones Industrial Average also saw declines. This fall...

    MarketWatch•10/13/26•Somewhat-Bearish

    Teleflex Inc Share Price - TFX, RNS News, Articles, Quotes, & Charts (NYSE:TFX)

    This page provides an overview of Teleflex Inc (NYSE:TFX), a medical technology company. It includes current stock information such as price, day change, market cap...

    Proactive financial news•10/13/26•Neutral

    Teleflex Incorporated (TFX) Stock forecasts

    This page is a placeholder for Teleflex Incorporated (TFX) stock forecasts, but it currently displays an error preventing the data from loading. It is part of the Yahoo Finance platform...

    Yahoo Finance UK•10/12/26•Neutral

    Teleflex completes enrollment in BIOMAG-LL magnesium scaffold study

    Teleflex Incorporated has successfully completed patient enrollment for its BIOMAG™-LL Clinical Study, evaluating longer lengths of the Freesolve™ Resorbable Magnesium Scaffold for coronary lesions. The study...

    StreetInsider•10/12/26•Bullish

    TFX Valuation and Fair Value

    P/E
    14.6x
    Forward P/E
    11.0x
    EV/EBITDA
    97.6x
    P/FCF
    61.6x
    PEG
    0.2x
    P/B
    1.9x
    See GNG's fair value

    TFX Profitability: Margins, ROIC and FCF

    Gross margin
    57.6%
    Operating margin
    10.1%
    Net margin
    -45.8%
    ROIC
    -0.8%
    ROE
    -0.7%
    FCF margin
    5.6%
    FCF yield
    1.6%

    TFX Competitors

    CompanyTicker
    Stevanato Group SpASTVN
    Merit Medical Systems IncMMSI
    RadNet IncRDNT
    Mirum Pharmaceuticals IncMIRM
    Doximity IncDOCS
    Waystar Holding Corp. Common StockWAY
    CG Oncology, Inc. Common stockCGON
    Erasca IncERAS

    Sector: Healthcare

    TFX Analyst Ratings

    Consensus
    Buy
    Analysts
    13
    Strong Buy
    4
    Buy
    2
    Hold
    7
    Sell
    0
    Strong Sell
    0

    TFX Bull Case vs Bear Case

    Bull case

    • TFX beat EPS estimates in 87.5% of its last 8 reported quarters.
    • TFX grew quarterly revenue 28.9% year over year.

    Bear case

    • TFX has a -45.8% net profit margin.

    TFX Earnings: Beat Rate and Next Report

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    3.4%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $1.89
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    10 up, 0 down

    TFX Dividend

    Forward yield
    1.1%
    Payout ratio
    38.5%
    3Y DPS growth
    0.0%
    5Y DPS growth
    0.0%
    Pay months
    Mar, Jun, Sep, Dec
    TFX dividend history

    Frequently Asked Questions About TFX

    What is TFX's current dividend yield?

    Teleflex Incorporated (TFX) has a forward dividend yield of 1.06%.

    Does TFX pay dividends?

    Yes, Teleflex Incorporated pays dividends with a forward dividend yield of 1.06%.

    What is TFX's P/E ratio?

    Teleflex Incorporated has a price-to-earnings (P/E) ratio of 14.64.

    What is TFX's market cap?

    Teleflex Incorporated (TFX) has a market capitalization of $5.22B with a current stock price of $128.11.

    Related stocks

    Sector: Healthcare

    All stocks starting with T

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In